Syros Pharmaceuticals (FRA:0S90) 1-Year Share Buyback Ratio : -29.50% (As of Sep. 2024 )

View and export this data going back to 2016. Start your Free Trial

What is Syros Pharmaceuticals 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Syros Pharmaceuticals's current 1-Year Share Buyback Ratio was -29.50%.

FRA:0S90's 1-Year Share Buyback Ratio is ranked worse than
67.25% of 1200 companies
in the Biotechnology industry
Industry Median: -13.65 vs FRA:0S90: -29.50

Competitive Comparison of Syros Pharmaceuticals's 1-Year Share Buyback Ratio

For the Biotechnology subindustry, Syros Pharmaceuticals's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syros Pharmaceuticals's 1-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syros Pharmaceuticals's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Syros Pharmaceuticals's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Syros Pharmaceuticals 1-Year Share Buyback Ratio Calculation

Syros Pharmaceuticals's 1-Year Share Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Sep. 2023 )	-	Shares Outstanding (EOP) (Sep. 2024 ))	/	Shares Outstanding (EOP) (Sep. 2023 )
	=	(20.720	-	26.832)	/	20.720
	=	-29.5%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syros Pharmaceuticals (FRA:0S90) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Syros Pharmaceuticals 1-Year Share Buyback Ratio Related Terms

Syros Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syros Pharmaceuticals Inc (FRA:0S90) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

SYRS:USA 0LC7:UK

Address

35 CambridgePark Drive, 4th Floor, Cambridge, MA, USA, 02140

Website

https://www.syros.com

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Syros Pharmaceuticals Headlines

No Headlines